Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02119065 · ClinicalTrials.gov registry record
Pilot Study to Assess Lung Shunting of Yttrium-90 Microspheres Using PET/CT
A clinical trial of Liver Metastases and Advanced Adult Primary Liver Cancer, sponsored by University of Cincinnati.
- Active
- Registry status
- 6
- Enrollment target
- 1
- Study location
NCT02119065: Active study of Liver Metastases and Advanced Adult Primary Liver Cancer, sponsored by University of Cincinnati.
NCT02119065 is a study of Liver Metastases and Advanced Adult Primary Liver Cancer that is active but no longer recruiting, run by University of Cincinnati. The registered enrollment target is 6 participants, below the 68-participant average among 27 other Liver Metastases trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02119065, a study of Liver Metastases and Advanced Adult Primary Liver Cancer, is active but no longer recruiting, sponsored by University of Cincinnati.
- ACTIVE NOT RECRUITING
- Registry status
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot clinical trial studies positron emission tomography (PET)/computed tomography (CT) in finding beads after Yttrium-90 bead therapy in patients with primary liver cancer or cancer that has spread to the liver (metastatic) that can not be removed by surgery. Imaging procedures, such as PET/CT after Yttrium-90 bead therapy, may help see if the beads are present in the lung and compare the results with the pre-therapy imaging.
Primary Outcome
Non-parametric Wilcoxon signed rank testing will be used to compare the 99mTc MAA and 90Y microsphere shunt fractions. Alternatively, a natural log transformation of the hepatopulmonary shunt fractions may be used to normalize these data for subsequent parametric paired t-test analysis.
Conditions Studied
Interventions
- PROCEDURE positron emission tomography
- PROCEDURE computed tomography
Study Locations (1)
Ohio
- Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2014-01-30 |
| Est. Completion | 2026-12-31 |
What the registry record for NCT02119065 still lists
NCT02119065 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 68-participant average among 27 other Liver Metastases trials with a reported enrollment target (91% lower).
The record links to 4 conditions, with Liver Metastases appearing as the primary indexed condition, and to 2 interventions - of which positron emission tomography is the first listed.
NCT02119065 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT02119065 about?
NCT02119065 is a clinical study titled "Pilot Study to Assess Lung Shunting of Yttrium-90 Microspheres Using PET/CT". This pilot clinical trial studies positron emission tomography (PET)/computed tomography (CT) in finding beads after Yttrium-90 bead therapy in patients with primary liver cancer or cancer that has spread to the liver (metastatic) that can not be removed by surgery. Imaging procedures, such as PET/C...
What is the current status of trial NCT02119065?
This trial is currently active not recruiting. The enrollment target is 6 participants. The study started on 2014-01-30. Estimated completion is 2026-12-31.
What conditions does trial NCT02119065 study?
This clinical trial studies the following conditions: Liver Metastases, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer.
What interventions are being tested in trial NCT02119065?
The interventions under investigation include: positron emission tomography (PROCEDURE), computed tomography (PROCEDURE).
Who is sponsoring clinical trial NCT02119065?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02119065 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Metastases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02119065's enrollment target sits among peer trials
6 26th of 27 higher than 2 of 27 other Liver Metastases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Liver Metastases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Promoting Immunotherapy Efficacy With Low-Dose Liver RT
RECRUITING · NA
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
-
A Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal Cancer
RECRUITING · Phase 2
-
Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis
RECRUITING · NA
-
REGULUS: MRI-guided Adaptive SABR for Liver Cancers
RECRUITING · Phase 2
-
OAR-Based, Dose Escalated SBRT With Real Time Adaptive MRI Guidance for Liver Metastases
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI